Oesophageal cancer: DNA breakthrough
An abnormality in DNA shared by some oesophageal cancer patients discovered by Queensland researchers could be an important... Read More
Engage Forums: November 2014
Three Engage Community Forums on Gastro-Intestinal Cancer will be presented by the GI Cancer Institute / AGITG in... Read More
Korean researchers gain new insights
Dr Boram Han (second from right), pictured in Sydney with AGITG Research Fellows (L-R) Dr Katrin Sjoquist, Dr... Read More
TV appeal for support
GI Cancer Institute and AGITG Executive Officer Russell Conley has told TV audiences in Australia and New Zealand... Read More
Chinese research links sought
Immediate Past Chair of the AGITG, and Current Chair of the AGITG’s new International Development Committee, Professor John... Read More
Aspirin studies “promising”: AGITG
An AGITG Board member has welcomed new findings on the role of aspirin in reducing deaths from bowel... Read More
Bile duct trials offer hope
Support from donors is funding AGITG’s role in key international initiatives to find better treatments for aggressive bile... Read More
GI cancers lag in research funding
Gastro-intestinal (GI) cancers are among the worst-funded in Australia, compared with their impact in lives lost, a new... Read More
Great Engagement at Brisbane ASM
The AGITG held its 16th Annual Scientific Meeting (ASM) in Brisbane on August 20-22. It was preceded by... Read More
Worldwide aspirin-bowel cancer study opens in Orange
A landmark worldwide research trial on the role of aspirin in bowel cancer treatment has opened its Australian-New... Read More
Pancreatic workshop signals “new era of collaboration”
A workshop on the latest research on treatment of pancreatic cancer on August 19 at the Sofitel Central,... Read More
Second AGITG Preceptorship in Colorectal Cancer
Second AGITG Preceptorship in Colorectal Cancer One of the many callings that Associate Professor Eva Segelov has is in... Read More
Prediabetes linked with some GI cancers
A review of 16 studies has found that having prediabetes may increase risk of cancers by 15% —... Read More
Behind the scenes with AGITG researchers
Behind every new treatment is years of research and clinical trials. Playing an important role in clinical trial... Read More
AGITG 2014 Annual General Meeting
The 2014 AGITG Annual General Meeting was held on Friday 16th May 2014 at Rydges Sydney Airport Hotel. Professor... Read More
AGITG at ASCO
The American Society of Clinical Oncology (ASCO) promotes and provides for lifelong learning for oncology professionals; cancer research;... Read More
First ACTA Summit held in Melbourne
The Australasian Gastro-Intestinal Trials Group (AGITG) is delighted to have been involved in the first Australian Clinical Trials... Read More
A trial to reduce fear of cancer recurrence
Fear of cancer recurrence (FCR) is one of the most frequently reported unmet needs among cancer survivors, yet... Read More
AGITG Abstracts at ASCO GI – San Francisco
The 2014 GI Cancers Symposium is a specialised meeting designed to highlight the latest science in cancers of... Read More
ASCOLT study secures funding
The ASCOLT study, which will test if aspirin can reduce the recurrence of bowel cancer and improve survival... Read More